Understanding the FDA’s Draft Guidance on Protocol Deviations in Clinical Investigations
The U.S. Food and Drug Administration (FDA) has released a draft guidance document titled Protocol Deviations for Clinical Investigations of...
Moe Alsumidaie
PathAI: Clinical Trial Pathology Revolution
In this interview, we engage with PathAI leaders: Eric Walk, MD, Chief Medical Officer; Ella Stewart, Senior Product Manager;...
Azitra: Revolutionizing Skin Disease Treatment
In this interview, Francisco Salva, CEO of Azitra, shared insights into the company’s innovative approach to treating skin diseases....
Move Over Pharma: Patient-Led Organizations Advance Rare Disease Clinical Trials
At the 2025 SCOPE Summit, industry leaders and patient advocates discussed a transformative shift in the pharmaceutical industry: patient-led...
Pharma’s Future: Graham Clark on Trends and Challenges
In the dynamic world of pharmaceuticals, staying ahead of trends and challenges is vital. Graham Clark, CEO of Phastar,...
2025 SCOPE Summit: Advancing Patient-Centric Clinical Trials
The 2025 SCOPE Summit brought together industry leaders to explore patient-centric approaches in clinical trials, addressing the critical issue...
Medable’s France CNIL Regulatory Breakthrough: Pioneering Global Clinical Trials
Medable has achieved a significant milestone by securing regulatory approval from France’s CNIL, enhancing its global clinical trial capabilities....
Pragmatic Trials? All Talk, No Real Progress
Pragmatic clinical trials have become one of the industry’s favorite buzzwords, but where’s the real progress? Every year, the...
Revolutionizing Clinical Trials with AI and Decentralization
In the evolving world of clinical trials, AI and decentralization are key drivers of change. Iddo Peleg, CEO of...
Transforming Clinical Trials with AI: Insights from the Frontline
In the rapidly evolving landscape of clinical trials, technology is a game-changer. Dr. Michelle Papka, Ph.D., Founder and President...